2/17
10:20 am
nmra
Rating for NMRA
Medium
Report
Rating for NMRA
2/17
10:20 am
nmra
Rating for NMRA
Medium
Report
Rating for NMRA
2/17
07:23 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Medium
Report
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
2/17
07:23 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Medium
Report
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
2/17
06:00 am
nmra
Neumora upgraded to Outperform from Market Perform at William Blair
Medium
Report
Neumora upgraded to Outperform from Market Perform at William Blair
2/17
06:00 am
nmra
Neumora upgraded to Outperform from Market Perform at William Blair
Medium
Report
Neumora upgraded to Outperform from Market Perform at William Blair
1/12
08:04 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $8.00 price target on the stock.
Low
Report
Neumora Therapeutics (NASDAQ:NMRA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $8.00 price target on the stock.
1/12
07:43 am
nmra
Rating for NMRA
Medium
Report
Rating for NMRA
1/12
05:20 am
nmra
Neumora Therapeutics initiated with an Outperform at Leerink
Low
Report
Neumora Therapeutics initiated with an Outperform at Leerink